Research & Development Market Research Reports & Industry Analysis
Bringing R&D costs and times down, therefore, means there are many opportunities to improve efficiencies, advance technological innovation, and economize and optimize. The pharmaceutical R&D category tracks both drug pipeline reports, competitive R&D strategies, and markets important and ancillary to the research efforts themselves, including activities in the biotech and sector that impinge upon the process.
Research & Development Industry Research & Market Reports
-
Cold Plasma Global Market Report 2025
... is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond. Reasons to Purchase Gain a truly global perspective with the ... Read More
-
Biotechnology Product Manufacturing
... the US), as well as Bayer and Merck Group (both based in Germany), CSL (Australia), Novo Nordisk (Denmark), and the biotech research arms of major international pharmaceutical companies such as Sanofi (France). COMPETITIVE LANDSCAPE Biotech ... Read More
-
Pharma And Biotech CRM Software Global Market Opportunities And Strategies To 2034
... and biotech CRM software market as it emerges from the COVID-19 shut down. Reasons to Purchase Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies. Understand how ... Read More
-
Biotech Research and Development - US Industry Market Research Report with Recession Risk Analysis & Forecasts
... Insights report is full of industry insights including historical and forecasted market size, revenue and industry breakdowns by product lines, size of company, concentration segmentation, business structure, customer type, state and MSA, profitability, financial ratios, ... Read More
-
2025 Biotech Research and Development Global Market Size & Growth Report with Updated Country Recession Risk Forecasts
... with forecasts for 2025 and 2029. The historical data utilizes in-depth survey results from companies in the Biotech Research and Development industry combined with country and regional economic, firmographic, and demographic data. Our analysts develop ... Read More
-
In Situ Hybridization Market by Offering (Consumables, Instruments, Software), Technology (FISH (DNA FISH, RNA, PNA), CISH), Application (Cancer Diagnostics, Research, Discovery), End User (Hospitals, Pharma & Biotech, Academia) - Global Forecast to 2030
... hybridization (ISH) market is largely driven by continuous technological advancements within ISH platforms. Innovations such as enhanced probe designs, automation, and multiplexing capabilities have markedly improved assay sensitivity, specificity, and throughput. These enhancements align with ... Read More
-
Cell Banking Outsourcing Market Forecasts to 2032 – Global Analysis By Type (Master Cell Banks (MCB), Working Cell Banks (WCB) and Viral Cell Banking (VCB)), Cell Type (Stem Cell and Non-stem Cell), Phase, End User and By Geography
... period. Cell banking outsourcing is assigning specialized third-party service providers to create, store, and maintain cell banks, including master cell banks (MCBs) and working cell banks (WCBs). By utilizing the infrastructure and experience of CDMOs, ... Read More
-
The Global Synthetic Biology (SynBio) Market 2026-2036
... 2024, the market is projected to experience explosive growth, driven by advances in genetic engineering, computational design, and automated biological systems. The synthetic biology market is experiencing robust growth at a compound annual growth rate ... Read More
-
Worldwide Biotech July 2025
... an international industry, reporting on the deals between U.S. biotechnology companies and international pharmaceutical corporations. Monitors the emerging European Community marketplace and the growing Japanese interest and deals in the U.S. biotechnology and pharmaceuticals industry. Read More
-
Biotech Business July 2025
... on biotechnology products and companies. It reports which universities offer licensing of biotechnology research, which companies have entered licensing agreements, as well as the financial health of biotechnology companies and their expected growth or decline. Read More
-
Induced Pluripotent Stem Cell (iPSC) Derived Organoids
... expected to reach US$1.7 Billion by 2030, growing at a CAGR of 19.8% over the analysis period 2024-2030. Brain Organoids, one of the segments analyzed in the report, is expected to record a 21.7% CAGR ... Read More
-
Biotech Equipment Update July 2025
Biotech Equipment Update covers news and the latest information about biotechnology lab and manufacturing equipment and products. This includes new product and technology announcements, as well as vendor research, development, and manufacturing information. Read More
-
Biotech Financial Reports July 2025
BIOTECH FINANCIAL REPORTS provides the latest financial information and news on biotech and pharmaceutical companies. This includes quarterly and annual reports plus merger and acquisition news, and stock dividend announcements. Read More
-
Residual DNA Testing Market by Product & Service (Consumable, Instrument & Software), Technology (PCR), Test Type (Raw, Final, Bulk Lot Release Testing), Application (mAb, CGT, Vaccine), End User (Pharma & Biotech, CRO & CDMO) - Global Forecast to 2030
... fueled by multiple factors, including the increasing frequency of approvals for biologics and biosimilars, as well as the implementation of rigorous regulatory frameworks governing the manufacture of biopharmaceutical products. Additionally, advancements in technologies related to ... Read More
-
Guangzhou Wondfo Biotech Co Ltd (300482) - Product Pipeline Analysis, 2025 Update
... kits. It also offers fertility and thyroid testing devices, immunofluorescence reagents, molecular diagnostic equipment, blood gas, coagulation analyzers and dry chemistry analyzers. The company's products are widely used in the rapid diagnosis and effective treatment ... Read More
-
The 2026-2031 World Outlook for Bioburden Testing
... (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using econometric models which ... Read More
-
The 2026-2031 World Outlook for Cold Plasma
... (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using econometric models which ... Read More
-
The 2026-2031 World Outlook for Clinical Contract Research Outsourcing
... in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using econometric ... Read More
-
The 2026-2031 World Outlook for Circulating Tumor Cells
... question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using econometric models ... Read More
-
The 2026-2031 World Outlook for Autologous Bone Marrow Transplants
... in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using econometric ... Read More
-
The 2026-2031 World Outlook for Lab-on-a-Chip
... millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using econometric models which project ... Read More
-
The 2026-2031 World Outlook for Biosimulations
... millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using econometric models which project ... Read More
-
The 2026-2031 World Outlook for Cold Laser Therapies
... question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using econometric models ... Read More
-
The 2026-2031 World Outlook for Biotechnologies
... millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using econometric models which project ... Read More
-
The 2026-2031 World Outlook for 3D Bioprinting Products
... question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using econometric models ... Read More
Research Assistance
